ANALYSES OF THE SIGNAL TRANSDUCTION OF NOVEL ANTI-ARTHRITIC FACTOR, FRP, AND ITS EFFECTS ON IMMUNE SYSTEM
ANALYSES OF THE SIGNAL TRANSDUCTION OF NOVEL ANTI-ARTHRITIC FACTOR, FRP, AND ITS EFFECTS ON IMMUNE SYSTEM
批准号:
18591105
负责人:
TANAKA Masao
金额:
$2.51万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Molecular interaction analysis of FRP receptor, A7: Our BIACORE studies disclosed that FRP actually bound to A7 and CD14, and also to activin A, follistatin, TGF-beta1. Their K_D values were calculated as follows: 4.20×10^<-6>M for FRP and A7, 1.72×10^<-4>M for FRP and CD14, 1.43×10^<-6>M for FRP and activin A, 1.88×10^<-4>M for FRP and follistatin, 1.28×10^<-8>M for FRP and TGF-beta1. K_D values for other binding pairs could not be decided. FRP was characterized by having extremely high speed and comparatively low affinity binding activity for partner molecules except for TGF-beta. Activin A and CD14 didn't bind to A7, however, follistatin bound weekly and quite slowly to A7, and they all interfered with FRP binding to A7. Interestingly, TGF-beta1 also bound to A7 with relatively-high affinity. However, bound TGF-beta1 seemed to be substituted by a larger amount of FRP, judging from its characteristic rectangular sensorgram. FRP trivially interfered TGF-beta1 binding to TGF-beta1sRII with a little competition, therefore, it seemed that FRP could hardly impede TGF-beta signaling. Taken together, FRP seems to interact with TGF-beta family proteins, and thereby play an important part in the tissue formation including the immune system.2. Cloning of second messengers in FRP signaling system: All of the resultant two-hybrid clone cells, SA240, SA263, SB224, SC21, SC23 proved to lack prey vectors, probably because their product proteins could be toxic to host cells. This brought us to consider cloning by another two-hybrid system not with yeast but with bacteria, whose species is more distant from the mammals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
診療ガイドダイジェスト リウマチ/膠原病 シェーグレン症候群
医疗指南消化风湿病/胶原病干燥综合症
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[Yoshifuji, H., Fujii, T., Kobayashi, S., Imura, Y., Fujita, Y., Kawabata, D., Usui, T., Tanaka.M, Nagai, S., Umehara H., Mimori, T., 真柄 鮎子, 真柄 鮎子, Magara A., 田中 真生, Tanaka M., Magara A., 田中 真生]
通讯作者:
田中 真生
Successful treatment of primary Sjogren's syndrome with chronic natural killer lymphocytosis by higy-dose prednisolone and indomethacin farnesil.
大剂量泼尼松龙和吲哚美辛法尼西成功治疗伴有慢性自然杀伤淋巴细胞增多的原发性干燥综合征。
DOI:
--
发表时间:
2007
期刊:
Intern. Med. 46・5
影响因子:
--
作者:
[Fujita Y., Fujii T., Takeda N., Tanaka M., Mimori T.]
通讯作者:
Mimori T.
DOI:
10.1007/s10165-006-0560-9
发表时间:
2007-01-01
期刊:
Modern rheumatology
影响因子:
2.2
作者:
[Ito, Yoshinaga, Kawabata, Daisuke, Mimori, Tsuneyo]
通讯作者:
Mimori, Tsuneyo
Analysis of clinical significance of anti-cyclic citrullinated peptide antibody(anti-CCP antibody)in rheumatoid arthritis(RA)
抗环瓜氨酸肽抗体(抗CCP抗体)在类风湿性关节炎(RA)中的临床意义分析
DOI:
--
发表时间:
2007
期刊:
Nihon Rinsho Meneki Gakkai Kaishi 30
影响因子:
--
作者:
[Okuzawa C, et. al., Fukushima T., Fujita Y., Fukushima T., Fujita Y., Fukushima T., Fujita Y., Dong L., Umehara H., Shimoyama K., Kawanami T., Dong L., Umehara H., Shimoyama K., Kawanami T., Dong L., Shimoyama K.]
通讯作者:
Shimoyama K.
抗CD20抗体(リツキシマブ)療法が有効であったバセドウ病合併SLE難治性血小板減少症の一例
SLE难治性血小板减少症并发格雷夫斯病抗CD20抗体(利妥昔单抗)治疗有效一例
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Yoshifuji, H., Fujii, T., Kobayashi, S., Imura, Y., Fujita, Y., Kawabata, D., Usui, T., Tanaka.M, Nagai, S., Umehara H., Mimori, T., 真柄 鮎子]
通讯作者:
真柄 鮎子
共 18 条
A new strategy for improving the efficacy of the conventional therapy of pancreatic cancer by remodeling its microenvironment
-
批准号:25670586
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2013
-
负责人:TANAKA Masao
-
依托单位:
Identifying the leading cell for the invasion of pancreatic cancer
-
批准号:24390318
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2012
-
负责人:TANAKA Masao
-
依托单位:
Establishment of therapy for individual based on diagnostic imaging by artificial virus
-
批准号:23659655
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:TANAKA Masao
-
依托单位:
Prospective isolation of pancreatic cancer cells with highly malignant phenotype and development of future individualized therapy
-
批准号:21390381
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2009
-
负责人:TANAKA Masao
-
依托单位:
Tailor-made NK4-gene therapy for pancreatic cancer using nano devise.
-
批准号:16209040
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.95万
-
财政年份:2004
-
负责人:TANAKA Masao
-
依托单位:
A conceptual framework for the next generation of the supply chain management
-
批准号:15530287
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2003
-
负责人:TANAKA Masao
-
依托单位:
Analysis and modeling of micro- or nano-scale structure and microcirculation of bone
-
批准号:15086210
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$20.93万
-
财政年份:2003
-
负责人:TANAKA Masao
-
依托单位:
Patient specific individual computational mechanics for diagnosis and treatment planning of temporomandibular joint disorder
-
批准号:14380402
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.54万
-
财政年份:2002
-
负责人:TANAKA Masao
-
依托单位:
Treatment of pancreatic cancer by HGF antagonist, NK4, through new drug delivery system. -Approach from bench to practice
-
批准号:13470257
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2001
-
负责人:TANAKA Masao
-
依托单位:
Patient specific indibidual computational bio-mechanics of temporomandibular joint system and application to temporomandibular disorder examination
-
批准号:12680830
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2000
-
负责人:TANAKA Masao
-
依托单位:
Modeling of adaptive bone remodeling and its application to optimal design of structure/material system (Approach to multilevel structural system)
-
批准号:10650088
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1998
-
负责人:TANAKA Masao
-
依托单位:
New strategy against pancteato-biliary carcinoma using NK4, a four-kringle antagonist of hepatocyte growth factor
-
批准号:10470259
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.0万
-
财政年份:1998
-
负责人:TANAKA Masao
-
依托单位:
Numerical analysis on the dynamics of communities for sessile colonial animals
-
批准号:07640843
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1995
-
负责人:TANAKA Masao
-
依托单位:
Practical Study or Teaching at University
-
批准号:01410007
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$4.22万
-
财政年份:1989
-
负责人:TANAKA Masao
-
依托单位:
Development of High-Speed Video Cameras and Study on Dynamic Deformation Behavior of Materials
-
批准号:01850027
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B).
-
资助金额:$5.06万
-
财政年份:1989
-
负责人:TANAKA Masao
-
依托单位:
Evaluation of intra-specific or inter-specific competition for T. lubrica by a bio-economical method.
-
批准号:62540500
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1987
-
负责人:TANAKA Masao
-
依托单位:
海外基金